ValuationViz

LGND fund manager activity

Ligand Pharmaceuticals Incorporated · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q3 2013 to Q2 2026.

Q2 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed106,066$12,057,5810.00%Aug 13, 2025
Joel Greenblatt - Gotham Asset ManagementSold out——0.00%Aug 14, 2025
Tweedy BrowneNew3,140$356,9550.03%Jul 29, 2025

Q1 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded107,506$11,303,1790.00%May 14, 2025
Joel Greenblatt - Gotham Asset ManagementNew6,912$726,7280.01%May 15, 2025

Newer quarters · Older quarters